lunes, 28 de diciembre de 2020

Phase 3 trial of Novavax investigational COVID-19 vaccine opens | National Institutes of Health (NIH)

Phase 3 trial of Novavax investigational COVID-19 vaccine opens | National Institutes of Health (NIH)

No hay comentarios:

Publicar un comentario